Posters

P01 COMPARISON BETWEEN NSAID THERAPY AND MEDIAL PATELLAR TAPING IN OSTEOARTHRITIS PAIN
Myriam Hayati, Iran
P02 COLONİC ADENOCARCİNOMA; A RARE CAUSE OF COMPLEX REGIONAL PAIN SYNDROME
Duygu Silte Karamanlioglu, Turkey
P03 MULTIMODALI MANAGEMENT OF REFRACTORY OSTEOARTICULAR AND JOINTS PAIN IN PATIENTS
Agnes Mazic De Sonis, Belgium
P04 CONCURRENT VALIDITY OF DIFFERENT FUNCTIONAL AND NEUROPROTEOMIC PAIN ASSESSMENT METHODS IN THE RAT OSTEOARTHRITIS MONOSODIUM IODOACETATE (MIA) MODEL
Colombe Otis, Canada
P05 SPINAL NEUROPEPTIDES MODULATION AND MACROSCOPIC CARTILAGINOUS LESIONS IN A CHEMICAL RODENT MODEL OF OSTEOARTHRITIS
Eric Troncy, Canada
P06 ANALGESIC EFFICACY OF RYTVELA IN A SURGICAL RODENT MODEL OF OSTEOARTHRITIS PAIN
Eric Troncy, Canada
P07 THE EFFICACY OF A TRANSDERMAL HERBAL PATCH (ARTCURE®) IN THE TREATMENT OF LUMBER DISC HERNIATION: A RANDOMİZED PLACEBO-CONTROLLED CLINICAL AND MR IMAGING-BASED STUDY
Pinar Borman, Turkey
P08 FOREFOOT PAIN CORRELATES WITH THE SESAMOID ROTATION ANGLE EVALUATED BY ULTRASOUND IMAGING
Keisuke Matsubara, Japan
P09 EFFECT OF THE CAPACITIVE AND RESISTIVE ELECTRIC TRANSFER SYSTEM ON LOCAL BLOOD CIRCULATION, MUSCLE FLEXIBILITY, AND SUPERFICIAL AND DEEP TISSUE TEMPERATURES
Yuki Yokota, Japan
P10 THE ASSOCIATION OF TRANSVERSE ARCH WITH KINEMATICS AND KINETICS DURING GAIT
Tomofumi Matsushita, Japan
P11 ULTRASOUND-GUIDED VERSUS PALPATION-GUIDED LOCAL CORTICOSTEROID INJECTION THERAPY FOR TREATMENT OF PLANTAR FASCIITIS
Sherine Mahmoud Elsherif, Egypt
P12 EMARTRO: STUDY TO ASSESS COMORBIDITY IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
Josep Verges, Spain
P13 ANXIETY AND DEPRESSION IN KNEE OSTEOARTHRITIC PATIENTS: RESULTS FROM  EMARTRO STUDY
Marta Herrero, Spain
P14 A PROTEOMIC PANEL PREDICTS DRUG RESPONSE TO THE COMBINATION OF GLUCOSAMINE AND CHONDROITIN SULFATE
Helena Martinez, Spain
P15 CHONDROITIN SULFATE INHIBITION OF NF-ΚB ACTIVITY: ATTENTUATION OF HYALURONAN FRAGMENT INDUCED INFLAMMATORY RESPONSE IN MACROPHAGES BY CHONDROITIN SULFATE IS MEDIATED BY REDUCTION IN NF-ΚB ACTIVITY
Eulàlia Montell, Spain
P16 EFFECT OF DİFFERENT Q ANGLES ON TIBIOFEMORAL JOINT ALIGNMENT IN PATIENT WITH OSTEOARTHRITIS
Ferruh Taspinar, Turkey
P17 IN KNEE OSTEOARTHRITIS BONE CURVATURE CHANGES CAN PREDICT THE IMPACT OF TREATMENT ON CARTILAGE VOLUME LOSS: DATA FROM A TWO YEAR CLINICAL TRIAL
Johanne Martel-Pelletier, Canada
P18 CONSUMER PERCEIVED NEEDS FOR NON-HEALTH CARE SERVICES RELATED TO OSTEOARTHRITIS
Jessica Louise Fairley, Australia
P19 EFFECT OF PLATELET-RICH PLASMA IN SYMPTOMATIC KNEE OSTEOARTHRITIS: A RETROSPECTIVE STUDY
Aylin Dikici, Turkey
P20 MUSCULOSKELETAL PROBLEMS IN INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS
Betul Taspinar, Turkey
P21 TOWARDS A STRATEGY FOR SECONDARY FRACTURE PREVENTION IN QUEBEC
Marie-Claude Beaulieu, Canada
P22 POLYPHARMACY IN ELDERLY PATIENTS WITH HIP FRACTURE
Rubén Torres Gonzalez, Mexico
P23 FEMORAL DIAPHYSEAL FRACTURE AFTER LONG-TERM BISPHOSPHONATES THERAPY
Omer Dikici, Turkey
P24 TRIPLE PELVIC OSTEOTOMY FOR ACETABULAR RETROVERSION
Kenan Dehne, United Kingdom
P25 COMPLEMENT RECEPTOR 1 GENE POLYMORPHISMS IN TUNISIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Yousr Gorgi, Tunisia
P26 CARDIORESPIRATORY FITNESS AND CARDIOVASCULAR RISK FACTORS IN AXIAL SPONDYLOARTHRITIS
Ebru Köseoğlu, Turkey
P27 THE EFFECTIVENESS OF SPECIFIC EXERCISE TYPES ON CARDIOPULMONARY FUNCTIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: A SYSTEMATIC REVIEW
Ferruh Taspinar, Turkey
P28 CHRONOLOGICAL DIFFERENTIAL EFFECTS OF PROINFLAMMATORY CYTOKINES ON RANKL-INDUCED OSTEOCLAST DIFFERENTIATION OF CANINE BONE MARROW DERIVED MACROPHAGES
Suranji Wijekoon, Japan
P29 THE COEXISTENCE OF BEHCET’S DISEASE AND ANKYLOSING SPONDYLITIS: A CASE REPORT
Omer Dikici, Turkey
P30 SYNTHESIS OF PORCINE URICASE BIOCONJUGATE WITH POLY [OLIGO(ETHYLENE GLYCOL) METHYL ETHER METHACRYLATE] FOR THE TREATMENT OF GOUT
Abdul-Razak Masoud, Kazakhstan
P31 IMMUNOGENICITY OF CANDIDA URICASE BIOCONJUGATE WITH POLY [OLIGO(ETHYLENE GLYCOL) METHYL ETHER METHACRYLATE] (POEGMA) FOR THE TREATMENT OF GOUT
Alla Shramko, Kazakhstan
P32 INFLAMMATORY MICROENVIRONMENT IN SYNOVIAL TISSUE INFLUENCES COMPETENCY OF OSTEOCLASTOGENESIS OF OSTEOCLAST PRECURSORS DERIVED FROM CANINE JOINTS
Suranji Wijekoon, Japan
P33 RITUXIMAB CAN INDUCE REMISSION IN A PATIENT WITH ANKYLOSING SPONDYLITIS WHO FAILED ANTI-TNF-Α AGENT
Talal Abdullah, Saudi Arabia
P34 CONSUMER PERCEIVED NEEDS OF NON-HEALTHCARE SERVICES IN PEOPLE WITH INFLAMMATORY ARTHRITIS
Jessica Louise Fairley, Australia
P35 CRYSTAL-INDUCED SYSTEMIC SYNDROME (CRISYS). AN INNATE IMMUNE REACTION COMPLICATES MEDICAL PRACTICES
Periklis Vounotrypidis, Greece
P36 IMMUNE SYSTEM AND BONE CELLS IN EARLY RHEUMATOID ARTHRITIS
Ilaria Buondonno, Italy
P37 EFFICACY AND SAFETY OF BARICITINIB (BARI) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND INADEQUATE RESPONSE (IR) TO TUMOUR NECROSIS FACTOR INHIBITORS (TNFI): SUMMARY RESULTS FROM THE 24-WEEK PHASE 3 RA-BEACON STUDY
Bernard  Combe, France
P38 POLYMORPHISMS OF TOLL-LIKE RECEPTOR 4 AND CD14 GENES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
Yousr Gorgi, Tunisia
P39 BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS): PHASE 3 TRIAL RESULTS
Edward Keystone, Canada
P40 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND INAPPROPRIATE RESPONSE (IR) TO CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS): RESULTS FROM THE 24-WEEK (WK) PHASE 3 (PH3) RA-BUILD STUDY
Bernard Combe, France
P41 PERIOSTIN DEFICIENCY AGGRAVATES INFLAMMATION AND JOINT DESTRUCTION IN K/BXN SERUM TRANSFER MODEL OF RHEUMATOID ARTHRITIS
Young-Sool Hah, Korea
P42 TWO BIOMARKERS OF BIOLOGICAL AGE QUESTIONING PREMATURE AGING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
Antonio Gonzalez, Spain
P43 PREDICTIVE VALUE OF ANTI-CARBAMYLATED PROTEIN ANTIBODIES FOR RHEUMATOID ARTHRITIS IN PATIENTS WITH EARLY ARTHRITIS
Antonio Gonzalez, Spain
P44 INNATE LYMPHOID CELLS (ILCS) ARE DIFFERENTIALLY DISTRIBUTED IN SEVERAL INFLAMMATORY AND NON-INFLAMMATORY JOINT DISEASES
Gilles Boire, Canada